Clipping of news on Brazilian Culture, Law and Citizenship
 


Federal Justice

SUS will have to cover high-cost drugs

18/3/2010

This article was translated by an automatic translation system, and was therefore not reviewed by people.




SAO PAULO, March 17, 2010 - The Supreme Federal Court (STF) decided today that the National Health System (SUS) will ensure the delivery of medicines or pay for medical procedures where the patient being treated can not afford to do.
The decision, which a precedent for further action was taken at the trial of nine resources moved by the Union, states and municipalities to suspend court orders that kept the coverage in Brazil for treatment, surgical procedures, examinations and supply of drugs.

In one, the state of Alagoas challenged decision of the Court of the state that determined the supply of a drug used to treat leukemia. The patient claimed not to have a financial position to afford the treatment costs estimated at R$ 162 mil.
In other action, the State of Ceará appealed against the Supreme Court decision that guaranteed the five patients receiving high-cost medications used against Alzheimer's, cancer and rheumatoid arthritis.

Today's decision signals the understanding that the Supreme should adopt the trial of the action on the supply of high-cost medicines.
In this case, the Court's decision will have repercussions in all actions on the subject in the Judiciary.

According to the minister Ricardo Lewandowski, to avoid a flood of lawsuits against the SUS, the Supreme should establish requirements for procedures, tests and medicines are provided to patients unable to afford treatment.
Lewandowski expressed concern over attempts of fraud and illegal trade.

"It is possible that the Supreme Court to establish conditions or requirements for the supply of medicines by SUS," the minister opined. The information is the Agency Brazil.

(Redação - Agency IN)

18:36 - 17/03/2010

Source: Portal Jornal do Brazil

 

This article was translated by an automatic translation system, and was therefore not reviewed by people.

Important:
The JurisWay site does not interfere in the work provided by doctrine, why only reflect the opinions, ideas and concepts of their authors.


  Subjects list
 
  Copyright (c) 2006-2009. JurisWay - All rights reserved.